ArticleJACC. Case reports2026
Transhepatic Access for Left Atrial Appendage Closure in a Patient With Inferior Vena Cava Interruption.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeft atrial appendage occlusion (LAAO) is an alternative stroke-prevention strategy in patients with nonvalvular atrial fibrillation who have contraindications to oral anticoagulation. Femoral venous access is the standard approach. CASE SUMMARY: We report a 78-year-old woman with nonvalvular atrial fibrillation, high bleeding risk due to recurrent falls, and prior traumatic subdural hematoma, referred for LAAO. The initial procedure attempt was aborted after intraprocedural discovery of congenital inferior vena cava interruption, precluding femoral access. In a second stage, the procedure was successfully completed via transhepatic venous access without complications. DISCUSSION: This case highlights the feasibility of transhepatic access for structural heart interventions in patients with complex venous anatomy. TAKE-HOME MESSAGES: Transhepatic access is a safe alternative for LAAO in patients with inferior vena cava interruption. Preprocedural imaging and flexible access strategies are essential in structural interventions for patients with complex venous anatomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.